報價延遲最少15分鐘:2024/11/16 10:11 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
9.96 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.50/0.47
|
|
企業價值
1.99B
|
| 資產負債 |
|
每股賬面淨值
6.49
|
| 現金流量 |
|
現金流量率
0.04
|
| 損益表 |
|
收益
354.34M
|
|
每股收益
1.57
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/11/16 10:11 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region. |